Work

Developing potential cellular and gene therapy products - frequently asked questions (from Catapult's regulatory round-up for November 2024)

Year: 2025

Type: other

Abstract: The FDA has issued a draft guidance intended to provide industry with answers to frequently asked questions (FAQs) and commonly faced issues that arise during the development of cellular and gene therapy products. Comments are due by 18th February 2025. Published on the 3rd of december 2024. Read the entire Regulatory Round-up – November 2024 here.

Source: Industrias Culturais (Universidade de Coimbra)

DOI: 10.58079/13axo

Author: Adelage

Language: English

Topic: Biomedical Ethics and Regulation

Subfield: Physiology

Field: Medicine

Domain: Health Sciences

Open Access status: green

OpenAlex ID: W6936560201

Cites:

Cited by:

Related to: